• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Aptus Pharma Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
544529
INE15XJ01010
11.6537026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
317.28
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

simplex papers ltd
Religare Enterprises consolidated net profit declines 16.52% in the March 2026 quarter
May 13,2026
Net profit of Religare Enterprises declined 16.52% to Rs 82.21 crore in the quarter ended March 2026 as against Rs 98.48 crore during the previous quarter ended March 2025. Sales rose 38.65% to Rs 327.12 crore in the quarter ended March 2026 as against Rs 235.93 crore during the previous quarter ended March 2025.

For the full year,net profit declined 31.02% to Rs 85.96 crore in the year ended March 2026 as against Rs 124.62 crore during the previous year ended March 2025. Sales rose 17.43% to Rs 1156.18 crore in the year ended March 2026 as against Rs 984.54 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales327.12235.93 39 1156.18984.54 17
OPM %43.60100.57 -11.7332.01 -
PBDT138.75239.46 -42 134.33305.30 -56
PBT127.17222.11 -43 87.26243.30 -64
NP82.2198.48 -17 85.96124.62 -31